A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients.

Anna Isabella PisaniAntonio ScalfariFrancesco CrescenzoChiara RomualdiMassimiliano Calabrese

Published in: European journal of neurology (2021)

The SP-RiSc yielded a high performance in identifying MS patients with high probability to develop SPMS, which can help improve management strategies. These findings are the premise of further larger prospective studies to assess its use in clinical settings.

Keyphrases

multiple sclerosis
end stage renal disease
white matter
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
mass spectrometry
ms ms
rheumatoid arthritis
disease activity
patient reported outcomes